GLEOSTINE
Live / Registered — Registered and renewed (as of 18 Aug 2025)
What this means for you
Registered since 05 May 2015. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 05 May 2025).
Record
- Serial number
- 86266575
- Registration number
- 4733095
- Mark type
- Stylized text
- Filed
- 29 Apr 2014
- Published for opposition
- 05 Aug 2014
- Registered
- 05 May 2015
- Next maintenance due
- 05 May 2025
- Attorney of record
- Douglas R. Wolf
Goods and services
- Class 005 — Pharmaceuticals: Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer
Owner
- AZURITY PHARMACEUTICALS, INC., WOBURN, MA, US
- NextSource Biotechnology, LLC, Pompano Beach, FL, US
- NextSource Biotechnology, LLC, Miami, FL, US
- NextSource Biotechnology, LLC, Miami, FL, US
Prosecution history
- 18 Aug 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 18 Aug 2025 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 18 Aug 2025 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 18 Aug 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 05 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 Jun 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 05 Jun 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 05 Jun 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 05 Jun 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 28 May 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 06 Apr 2025 — TEAS SECTION 8 & 9 RECEIVED
- 05 May 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 30 Mar 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 30 Mar 2022 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 03 Jan 2022 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED